MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
Eva‐Maria Packeiser(University of Veterinary Medicine Hannover, Foundation), Hugo Murua Escobar(University of Rostock)
Cited by 14
Related Papers
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib
|International Journal of Molecular Sciences|2021|7